Academic Journal
Q1Journal of Gastroenterology and Hepatology (Australia)
About Journal of Gastroenterology and Hepatology (Australia)
About Journal of Gastroenterology and Hepatology (Australia)
Journal of Gastroenterology and Hepatology (Australia) is a peer-reviewed scholarly journal published by Wiley-Blackwell Publishing Ltd (United Kingdom). It focuses on Q1. Publication coverage spans 1986-2026.
Key indicators: ISSN 1440-1746, 0815-9319; H-index 162.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (162): Exceptionally high — 162 articles have each been cited at least 162 times. This indicates deep, sustained influence in the field.
Publishing in Journal of Gastroenterology and Hepatology (Australia)
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Journal of Gastroenterology and Hepatology (Australia)?
1440-1746, 0815-9319.
Who publishes Journal of Gastroenterology and Hepatology (Australia)?
Wiley-Blackwell Publishing Ltd.
What are Journal of Gastroenterology and Hepatology (Australia)'s metrics?
H-index 162.
Where do I submit to Journal of Gastroenterology and Hepatology (Australia)?
Via the official website.
Is Journal of Gastroenterology and Hepatology (Australia) peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Liver Disease Diagnosis and Treatment; Helicobacter pylori-related gastroenterology studies; Liver Disease and Transplantation; Hepatitis C virus research; Hepatitis B Virus Studies; Hepatocellular Carcinoma Treatment and Prognosis.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,620.00 USD; 3,840.00 EUR; 3,100.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Integrating Plain 2D Ultrasound and Clinical Data for Identification of At‐Risk MASH: A Multicenter Proof of Concept Study
Vigneshwaran Selvakumar, Jordan Jun Yi Low, Nicole S. Tang, Chuan X. Lau et al.
2026-10-16 · DOI: 10.1111/jgh.70763Comment on: “Diagnostic and Clinical Performance of Single‐Use Versus Reusable Gastrointestinal Endoscopes: A Systematic Review and Meta‐Analyses”
Isheeka Lohana
2026-10-16 · DOI: 10.1111/jgh.70840Multisystem Comorbidity in Idiopathic Gastroparesis: Clarifying Targeted Clinical Assessment
Marie‐Claire Seeley, Kate L. M. Anderson, Emma Tippett, Alan J. Hakim et al.
2026-10-15 · DOI: 10.1111/jgh.70820The Role of Gut Microbiota in Chronic Constipation and the Therapeutic Potential of Fecal Microbiota Transplantation
Xinxin Wang, Lu Wang, Yuedong Liu
2026-10-15 · DOI: 10.1111/jgh.70807A Risk‐Based Prioritization Model for Advanced Colorectal Neoplasia in Thailand: Strengths and Open Questions
Yuze Wu, Chengzhi Qiu
2026-10-15 · DOI: 10.1111/jgh.70816HCC Risk Is Not Surveillance Benefit: Interpreting Surveillance Thresholds in Elderly MASLD
Onur Can Kılınç
2026-10-15 · DOI: 10.1111/jgh.70843Impact of AI‐Assisted Endoscopy on Secondary Review and Referral Decisions in Gastric Cancer Screening: A Multicenter Real‐World Study
Sachiyo Onishi, Seiji Adachi, Masahito Shimizu
2026-10-15 · DOI: 10.1111/jgh.70823Letter to the Editor Regarding “BEAT‐B Study (Behavior, Aspirations, and Treatment Needs): A Mixed‐Methods Study of Patient Values, Preferences, and Barriers to Care Among People Living With Chronic Hepatitis B in South and Southeast Asia”
Zhenlin Zhang, Luojie Liu
2026-10-15 · DOI: 10.1111/jgh.70842Is Helicobacter pylori Status Responsible for the Altered Pharmacodynamics of Tegoprazan?
Muhammad Hanzla Shahzad, Muhammad Wajid Siddique
2026-10-14 · DOI: 10.1111/jgh.70814Methodological Considerations in Interpreting Dairy‐Free Diet Efficacy in Adult Eosinophilic Oesophagitis
Zia Ullah
2026-10-14 · DOI: 10.1111/jgh.70822Upadacitinib in East Asia: Translating Trial Results Into Maintenance Care
Lee Sheung, Piao Zheng
2026-10-14 · DOI: 10.1111/jgh.70813Comments on CCT2 Promotes Immune Escape in Colorectal Cancer by Regulating the JAK1‐STAT3‐PD‐L1 Axis
Toua Abbasi, Abdullah Abdullah, Asiya Shahzad
2026-10-14 · DOI: 10.1111/jgh.70817Letter to the Editor: Strengthening Scientific Rigor in Reviews of Post‐Translational Modifications in Pancreatic Cancer: Conceptual and Methodological Considerations
Khadija Eman, Fasiha Daud
2026-10-14 · DOI: 10.1111/jgh.70819Dietary and Microbial Determinants of Intestinal Sulfur Gas and Malodor: Mechanisms, Phenotypes, and Nutritional Mitigation
Aziz Ullah
2026-10-13 · DOI: 10.1111/jgh.70806Double Duty, Single Scope: Unmasking a Pancreatic Mass in Billroth II Anatomy
Akihiko Kida, Kosuke Satomura, Fumitaka Arihara, Azusa Kawasaki et al.
2026-10-13 · DOI: 10.1111/jgh.70804Endoscopic Surveillance After Endoscopic Resection of Superficial Esophageal Squamous Cell Carcinoma for Metachronous Head and Neck Cancers
Yuya Asada, Shunsuke Yoshii, Ryu Ishihara, Yuta Fujimoto et al.
2026-10-13 · DOI: 10.1111/jgh.70805Can a Non‐VCTE HCC Prediction Model Be Validated Exclusively in VCTE‐Assessed Patients?
Serdar Hıra
2026-10-13 · DOI: 10.1111/jgh.7081214‐Day Keverprazan–Amoxicillin Dual Therapy Versus Bismuth‐Containing Quadruple Therapy as First‐Line Treatment for Helicobacter pylori Eradication: A Prospective, Single‐Center, Randomized Controlled Trial
Yue Yu, Qiang She, Yan‐Bing Ding, Min Zhang et al.
2026-10-13 · DOI: 10.1111/jgh.70808From Mitochondrial Targeting to Mechanistic Dependency in Nanoparticle Therapy for Ulcerative Colitis
Kaan Zıkşahna, Murat Ihlamur
2026-10-13 · DOI: 10.1111/jgh.70809Heterogeneous Response Patterns to Multispecies Probiotics in Patients With Constipation During Pregnancy: An Exploratory Analysis of a Phase 2 Clinical Trial
Xu Zhiyue, Zhou Le, Ding Shengjie, Feng Ling et al.
2026-10-11 · DOI: 10.1111/jgh.70746Reviews
Community Reviews
Version History
October 9, 2026 at 8:06 pm
September 25, 2026